Ensho Health today announced an Ensho-authored abstract has been accepted for poster discussion and presentations at the 32nd International Symposium on ALS/MND, to be held December 7-10.
"This research describes important early work in developing practical tools neurologists can use to improve early detection of amyotrophic lateral sclerosis in the community,” said Dr. Taha Bandukwala, Ensho Health Co-Founder and Chief Medical Officer. "We are grateful to Dr. Angela Genge, Dr. Amer Ghavanini, Mitsubishi-Tanabe Pharma, and EOCI Pharmacomm for their support and involvement."
About Ensho Health
Ensho Health is a health technology company whose mission is to empower healthcare providers to do more with data. It realizes its mission with solutions that improve patient outcomes and facilitate groundbreaking research. It operates clinical data labs that make machine learning and other clinically validated algorithms for early detection and individualized treatment of rare and complex diseases accessible to physicians and their patients, and provide information extraction services for secondary use of data studies with its Apollo aEDC system.